Nkarta reports first quarter 2021 financial results and business progress

South san francisco, calif., may 13, 2021 (globe newswire) -- nkarta, inc. (nasdaq: nktx), a biopharmaceutical company developing engineered natural killer (nk) cell therapies to treat cancer, today reported financial results for the first quarter ended march 31, 2021.
NKTX Ratings Summary
NKTX Quant Ranking